Using these approaches, several studies have demonstrated skewed TCR repertoires and also clonal expansions of mainly CD8+ T cells with identical TRBV sequence (clonotypes) in the peripheral blood, cerebrospinal fluid (CSF), as well as brain lesions of MS patients (9–17). Here, CD8A is linked to myeloid sarcoma.